Home/Filings/4/0001808805-22-000026
4//SEC Filing

Patel Sujal M 4

Accession 0001808805-22-000026

CIK 0001808805other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:39 PM ET

Size

10.9 KB

Accession

0001808805-22-000026

Insider Transaction Report

Form 4
Period: 2022-03-03
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
  • Purchase

    Common Stock

    2022-03-03$3.60/sh+50,000$179,8909,914,388 total
  • Exercise/Conversion

    Common Stock

    2022-03-04$10.00/sh+100$1,0009,914,488 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-03-03100788,733 total
    Exercise: $10.00Exp: 2031-01-31Common Stock (100 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    5,280,476
  • Common Stock

    (indirect: By Trust)
    1,814,035
Footnotes (4)
  • [F1]Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.57 to $3.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
  • [F3]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
  • [F4]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 31, 2021.

Issuer

Nautilus Biotechnology, Inc.

CIK 0001808805

Entity typeother

Related Parties

1
  • filerCIK 0001378830

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:39 PM ET
Size
10.9 KB